Provided by Tiger Fintech (Singapore) Pte. Ltd.

ADiTx Therapeutics

2.23
+0.08003.72%
Post-market: 2.250.0200+0.90%19:58 EDT
Volume:106.42K
Turnover:234.81K
Market Cap:2.59M
PE:0.00
High:2.27
Open:2.15
Low:2.13
Close:2.15
Loading ...
Feb 29, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Correspondence

Form CORRESP - Correspondence
Feb 22, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Feb 21, 2024

Major Issues Report

Form 8-K - Current report
Feb 16, 2024

Major Issues Report

Form 8-K - Current report
Feb 15, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Correspondence

Form CORRESP - Correspondence
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Feb 09, 2024

Major Issues Report

Form 8-K - Current report
Feb 06, 2024

Major Issues Report

Form 8-K - Current report
Feb 06, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 02, 2024

Major Issues Report

Form 8-K - Current report
Feb 02, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 30, 2024

Major Issues Report

Form 8-K - Current report
Jan 26, 2024

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jan 19, 2024

Major Issues Report

Form 8-K - Current report
Jan 18, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jan 10, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations